Small incision lenticule extraction, originally called Femtosecond lenticule extraction, is a form of laser based refractive eye surgery developed by Carl Zeiss Meditec used to correct myopia, and astigmatism. Although similar to LASIKlaser surgery, the intrastromal procedure is novel in that it uses a single femtosecond laser referenced to the corneal surface to cleave a thin lenticule from the corneal stroma for manual extraction. It has been described as a painless procedure. For candidates to qualify for this treatment, they have their corneal stroma thickness checked to make sure that post operative thickness won't be too thin. The lenticule to be extracted is accurately cut to the correction prescription required by the patient using a photodisruption laser-tissue interaction. The method of extraction can be via a LASIK-type flap, but more recently a flapless technique makes a small tunnel incision in the corneal periphery. Currently in the US the procedure is only approved for nearsightedness. After the femtosecond laser has separated the lenticule, a blunt spatula is inserted through the incision between the lenticule and the stroma and carefully rotated to ensure that the lenticule is completely detached prior to removal by forceps. The procedure has been described as safe and predictable in treating myopia and astigmatism. Some theoretical advantages are that the technique is minimally invasive compared with other flap based treatments and no collateral damage occurs to surrounding tissue due to the high speed of the femtosecond laser. There are limited studies on corneal wound healing and inflammatory response after this treatment has been carried out. There is a suggestion that the expression of fibronectin which is associated with wound healing is less in this method compared with femtosecond-LASIK. Because SMILE treatment is relatively new compared with other laser correction treatments, result studies are limited, but postoperative five year outcomes indicate that the results have been stable after 5 years of follow-up. In some cases post operative tear secretion and dry eye syndrome have been observed along with similar post operative complications seen in LASIK surgery. As lenticule extraction techniques evolve, there is a possibility that extracted lenticules can be cryogenically preserved either for future donation, or re-implantation. Proof of concept has been carried out on primates where lenticules were extracted from monkeys and allogenically transplanted into other monkeys with positive results. Contoura Vision was compared against Small Incision Lenticule Extraction to check the effectiveness by Kanellopoulos AJ and the results were published in Journal of Refractive Surgery in 2017. At 3 months, 86.4% of the Contoura Vision group and 68.2% of the SMILE group had UDVA of 20/20 and 59.1% and 31.8%, respectively, had UDVA of 20/16. Spherical equivalent refraction was 95.5% for the Contoura Vision group and 77.3% for the SMILE group. Residual refraction cylinder was 81.8% for the Contoura Vision group and 50% for the SMILE group. Contrast sensitivity was 7.2 ± 1.01 in the Contoura Vision group and 6.20 ± 1.52 in the SMILE group. Objective Scatter Index measurements at 3 months were 1.35 in the Contoura Vision group and 1.42 in the SMILE group. The author concluded that Contoura Vision was found to be superior compared to SMILE for all the visual performance parameters that were studied, irrespective the parameters were subjective and objective.
